Hereditary Spastic Paraplegia - adult onset

Gene: ATP13A2

Green List (high evidence)

ATP13A2 (ATPase 13A2, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000159363
EnsemblGeneIds (GRCh37): ENSG00000159363
OMIM: 610513, ClinGen, DECIPHER
ATP13A2 is in 30 panels

1 review

Bryony Thompson (Royal Melbourne Hospital)

Green List (high evidence)

At least four families reported with HSP.
Created: 19 Apr 2020, 6:29 p.m. | Last Modified: 19 Apr 2020, 6:29 p.m.
Panel Version: 0.6

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Spastic paraplegia 78, autosomal recessive MIM#617225

Publications

History Filter Activity

16 Mar 2021, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: atp13a2 has been classified as Green List (High Evidence).

16 Mar 2021, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: ATP13A2 were set to

31 Dec 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: ATP13A2 was added gene: ATP13A2 was added to Hereditary Spastic Paraplegia - adult onset_RMH. Sources: Expert Review Green,Royal Melbourne Hospital Mode of inheritance for gene: ATP13A2 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: ATP13A2 were set to Spastic paraplegia 78, autosomal recessive, 617225; Kufor-Rakeb syndrome, 606693 AR; complicated hereditary spastic paraplegia; Adult-onset lower-limb predominant spastic paraparesis